Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells.
Saved in:
| Title: | Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells. |
|---|---|
| Authors: | Wang CA; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Hou YC; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Division of General Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Hong YK; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Tai YJ; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Shen C; Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Hou PC; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA., Fu JL; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Wu CL; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Cheng SM; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Hwang DY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Su YY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Center for Cancer Research,, Kaohsiung Medical University, Kaohsiung, Taiwan., Shan YS; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. ysshan@mail.ncku.edu.tw.; Division of General Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. ysshan@mail.ncku.edu.tw., Tsai SJ; Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. seantsai@ccu.edu.tw.; Department of Biomedical Sciences, National Chung Cheng University, No.168, Sect. 1, University Rd., Minhsiung, Chiayi, 621301, Taiwan. seantsai@ccu.edu.tw. |
| Source: | Molecular cancer [Mol Cancer] 2025 Jan 18; Vol. 24 (1), pp. 25. Date of Electronic Publication: 2025 Jan 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1476-4598 |
|---|---|
| DOI: | 10.1186/s12943-024-02207-4 |
